Fig 1.
Flow chart showing recruitment of the participants in the study.
Table 1.
Characteristics of study participants.
Table 2.
Standardized* prevalence (%; 95%CI) of spectrum# of NAFLD in the study population.
Table 3.
Presence of raised alanine transaminase (ALT) levels and any fibrosis according to the severity of fatty liver assessed by ultrasound.
Table 4.
Determinants of NAFLD (defined on ultrasound) in urban and rural subjects.
Fig 2.
Prevalence of NAFLD on ultrasound by age and sex among urban and rural study subjects.